Hospital Infection Control Committee: what NABH actually requires

Hospital-acquired infections, usually called HAIs, are one of the few clinical risks where the hospital itself is the source of harm rather than the disease the patient arrived with. A patient admitted for a routine surgery who develops a surgical site infection, a catheterised patient who develops a urinary tract infection, a ventilated ICU patient who develops pneumonia: these are not treatment failures in the usual sense. They are infections the patient acquired because they were inside a hospital, and a significant fraction of them are preventable with disciplined, documented, consistently enforced infection control practices.

This is why NABH accreditation dedicates an entire chapter of its hospital standards to Hospital Infection Control (HIC). It is not a section buried inside a larger quality chapter. It is a standalone chapter with its own standards, its own objective elements, and its own set of mandatory indicators that hospitals must report quarterly. NABH's position is clear: infection control is not a department. It is a hospital-wide programme, and it requires a formally constituted committee, a dedicated officer, active surveillance, an antibiotic stewardship programme, and documented evidence that all of these are actually functioning, not just written on paper.

The Infection Control Committee: who sits on it and what it actually does

The first structural requirement is the Infection Control Committee (ICC) itself. NABH expects this committee to be formally constituted by a written order or notification from the hospital's management, not informally assembled. The committee's composition, as expected by NABH and reflected in accredited hospitals' own published manuals, typically includes the Medical Superintendent or Chief Medical Officer as the chair or a senior member, an Infection Control Officer (ICO) who is usually an infectious disease specialist or a medical microbiologist, one or more Infection Control Nurses (ICN) trained in infection control practices and surveillance, the head of the microbiology department, nursing in-charges from key clinical areas, and representatives from surgery, medicine, and housekeeping.

The ICO is the technical lead of the programme. In a hospital with a microbiology department, the microbiologist often fills this role. In smaller hospitals without a dedicated microbiologist, the ICO may be a physician with additional training in infection control, though NABH assessors will look for documented evidence of that training. The Infection Control Nurse is the operational backbone: the person who actually collects surveillance data, monitors hand-hygiene compliance, conducts environmental rounds, and tracks whether the committee's decisions are being implemented on the ground. A commonly cited benchmark is two to three ICNs for every 100 beds, though NABH does not prescribe a rigid ratio so much as expect that the programme is adequately staffed for the hospital's size and complexity.

The committee must meet regularly. NABH expects at least quarterly meetings, though most accredited hospitals default to monthly in practice because quarterly is not frequent enough to act on surveillance data in a clinically meaningful way. What assessors check is not just the meeting schedule but the minutes themselves: whether HAI data was actually presented and reviewed, whether decisions were made based on that data, whether those decisions were tracked to closure in subsequent meetings, and whether the annual IPC programme document was signed off by the Medical Superintendent. Minutes that record only attendance and no discussion are a specific red flag during assessments.

HAI surveillance: the 11 mandatory indicators and what they actually measure

NABH defines eleven mandatory quality indicators that every accredited hospital must track and submit quarterly. Several of these are directly infection-related: surgical site infection (SSI) rate, intravascular device-associated bloodstream infection rate (sometimes called CLABSI, for central line-associated bloodstream infection), ventilator-associated pneumonia (VAP) rate, and catheter-associated urinary tract infection (CAUTI) rate. These are not optional reporting items. They are part of NABH's national benchmarking dataset, and a hospital that cannot produce this data with a defined denominator and a consistent collection methodology is not demonstrating a functioning surveillance programme, regardless of how low it claims its infection rates are.

The distinction between passive and active surveillance matters here. Passive surveillance means recording infections when a clinician happens to notice and report one. Active surveillance means a trained ICN actively reviews patient records, lab cultures, and clinical indicators on a defined schedule to identify infections that meet a standardised case definition, whether or not a clinician flagged them. NABH expects active surveillance, and the data must be presented to the ICC in a form that allows trend analysis, not just raw numbers. A quarterly SSI rate of 2.3% is useful. A note that says "some infections occurred" is not.

For hospitals building this capability for the first time, the practical starting point is usually the ICU, because that is where device-associated infections (CLABSI, VAP, CAUTI) concentrate and where the denominator data (device-days) is most readily available. Expanding surveillance to surgical wards (for SSI tracking by procedure type) and then to general wards is a natural progression, but NABH does not accept "we are still building the programme" as a reason for having no data at all during an assessment. The ICU management module in a hospital ERP is where this data typically originates, since device-days, ventilator-days, and catheter-days are byproducts of the charting nurses already do at the bedside.

Antibiotic stewardship: why NABH put it inside the infection control chapter

Antibiotic resistance does not arrive from outside the hospital. It is generated inside the hospital, one inappropriate prescription at a time, when broad-spectrum antibiotics are prescribed without culture data, when courses are extended beyond clinical need, or when restricted antibiotics are used as first-line treatment out of habit or availability rather than evidence. NABH's decision to include antibiotic stewardship within the HIC chapter rather than treating it as a standalone pharmacy issue reflects the reality that controlling resistance and controlling infections are the same programme, not two separate ones.

What NABH expects in practice is a functioning programme, not a policy document filed in a binder. That programme typically includes a hospital-specific antibiotic formulary approved by the Pharmacy and Therapeutics Committee, categorising antibiotics into first-line, second-line, and restricted tiers. It includes an antibiogram, the hospital's own annual compilation of microbiology culture and sensitivity data, showing which organisms are prevalent in the facility and which antibiotics they are resistant to. The antibiogram must be updated at least annually from the hospital's own data, not borrowed from a textbook or a neighbouring facility, and it must be made available to prescribers in a usable format, not locked in the microbiology department.

On top of this, NABH expects prescribing audits: a monthly review of a sample of antibiotic prescriptions against the formulary, with results reported back to the ICC. And it expects a culture-before-antibiotics policy for specific high-risk conditions such as sepsis, pneumonia, and urinary tract infections, with documented compliance rates rather than just a stated expectation. This is one of the areas where a hospital's pharmacy management system and its infection control programme must talk to each other, because the prescribing data lives in one system and the culture data lives in another, and the stewardship audit needs both.

Hand hygiene: the single most audited practice in any NABH survey

Hand-hygiene compliance monitoring is, by volume, the most frequently checked infection control practice during a NABH on-site assessment. It is also the practice most likely to be directly observed by assessors during their walkthrough, not just reviewed in documentation. The expectation is based on the WHO's "Five Moments for Hand Hygiene" framework: before touching a patient, before a clean or aseptic procedure, after body fluid exposure risk, after touching a patient, and after touching patient surroundings. Compliance is measured as a rate (observed compliant moments divided by total observed opportunities), and NABH expects the hospital to track this rate over time, not just conduct an occasional audit before a survey.

The practical infrastructure required to support this is not trivial: alcohol-based hand-rub dispensers at every patient-care point (bedside, procedure rooms, nursing stations), soap and running water at every handwashing station, training records for all clinical and housekeeping staff, and a defined audit methodology with trained auditors who observe and record compliance without the observed staff knowing they are being watched (or, in some programmes, with their knowledge but on a randomised schedule). Compliance data feeds into the ICC's review and should show a trend, ideally improving, but at minimum being tracked and acted on.

Environmental monitoring, sterilisation, and biomedical waste

Infection control extends beyond clinical procedures into the physical environment. NABH's HIC standards include environmental cleaning protocols with defined frequencies, responsibilities, and audit mechanisms. Operation theatres have specific requirements: zoning (restricted, semi-restricted, unrestricted), air changes per hour (a minimum of 20 for conventional OTs, with positive pressure relative to corridors), and regular environmental cultures to verify that cleaning and air handling are effective. ICU areas similarly have defined air-change requirements (typically 15 per hour, with a mix of fresh and recirculated air) and bed-spacing requirements (a minimum distance between adjacent beds to reduce cross-contamination, commonly 2.4 metres centre-to-centre). See our coverage of OT scheduling and surgical safety for how the physical and procedural sides of this connect.

Sterilisation validation is another area NABH assessors check carefully. Autoclaves must run with biological indicators (not just chemical indicators), and the results must be logged and traceable. Failed sterilisation cycles must be documented, investigated, and the affected instruments quarantined until a successful re-run is confirmed. Central Sterile Supply Departments (CSSDs) have their own set of practices and records that feed into the ICC's oversight.

Biomedical waste management falls squarely within the infection control programme's scope as well. NABH standard HIC.8 specifically addresses BMW handling: segregation at the point of generation, colour-coded containers, safe internal transport, and compliance with the BMW Rules 2016. The ICC's role here is oversight and audit, not day-to-day operations, but the audit records and any corrective actions taken are part of the infection control documentation NABH reviews.

What assessors actually check when they walk in

NABH on-site assessments are not a paper-only review. Assessors walk through clinical areas, observe practices in real time, and ask staff questions about protocols they should know. On infection control specifically, assessors commonly check for the ICC constitution order and recent meeting minutes (with evidence that data was reviewed and decisions tracked), the annual IPC programme document signed off by the Medical Superintendent, active HAI surveillance data presented in a format that shows trends, the antibiotic formulary and a current antibiogram (not one from three years ago), hand-hygiene compliance audit results (not just training records, but actual observed compliance rates), the availability and condition of hand-rub dispensers at point of care, environmental cleaning schedules and audit records, sterilisation validation logs with biological indicator results, and BMW segregation practices observed during the walkthrough itself.

The pattern of findings that most commonly trips up hospitals is not a missing policy. It is a policy that exists on paper but shows no evidence of ongoing compliance monitoring. A hand-hygiene policy with no compliance audit. An antibiotic formulary with no prescribing audit. An ICC that meets quarterly but whose minutes show no discussion of data. NABH assessors are trained to distinguish between a programme that is functioning and one that was assembled for the assessment, and the distinction usually comes down to whether the data shows a continuous trail or a sudden burst of documentation in the weeks before the survey.

Isolation precautions: standard versus transmission-based

Every infection control programme rests on two layers of precaution. Standard precautions apply to every patient, every time, regardless of known infection status: hand hygiene at the five WHO-defined moments, appropriate use of gloves and gowns when contact with blood or body fluids is anticipated, safe injection practices, and correct handling and disposal of sharps. These are not triggered by a diagnosis. They are the baseline for all patient contact, because a patient's infectious status is frequently unknown at the point of first contact.

Transmission-based precautions layer on top of standard precautions once a specific infection or suspected infection is identified, and they are categorised by how the organism spreads. Contact precautions (gown and gloves for anyone entering the room, dedicated or disinfected equipment) apply to organisms spread by direct or indirect contact, such as multidrug-resistant organisms or Clostridioides difficile. Droplet precautions (surgical mask within a defined distance of the patient) apply to organisms spread by respiratory droplets over short range, such as influenza or pertussis. Airborne precautions (N95 respirator, negative-pressure isolation room where available) apply to organisms that remain suspended in air and travel further, such as tuberculosis or measles. NABH assessors expect to see these precautions correctly identified, correctly signed at the patient's door, and correctly practised by staff observed during the walkthrough, not just described in the infection control manual.

The practical difficulty for most Indian hospitals is not knowing the precaution categories. It is having enough isolation capacity, correctly ventilated rooms for airborne precautions in particular, to actually implement them when multiple patients need isolation simultaneously. NABH does not expect every hospital to have unlimited negative-pressure rooms, but it does expect a documented protocol for what happens when isolation capacity is exceeded: cohorting patients with the same organism together, prioritisation criteria, and a clear escalation path. A hospital's bed management system is where this isolation status is typically flagged, so that a bed allocated to an isolation patient is not accidentally offered to a non-isolation admission by a nurse working from a different list.

Outbreak investigation: what happens when surveillance flags a cluster

Active surveillance exists to catch clusters before they become outbreaks, and NABH expects a defined protocol for what happens the moment a cluster is identified, not an improvised response assembled after the fact. A cluster is typically defined as two or more cases of the same organism, in the same unit, within a defined time window, that exceeds the unit's expected baseline rate. When the ICN identifies a potential cluster during routine surveillance, the protocol NABH expects includes immediate notification to the ICO, a line listing of affected patients with onset dates and relevant exposures, a review of whether a common source (a piece of equipment, a staff member, a procedure, a batch of a product) can be identified, and enhanced precautions for the affected unit while the investigation proceeds.

The outbreak investigation itself follows a structured epidemiological approach even in a hospital setting: establishing a case definition, identifying all cases meeting that definition (not just the index cases that triggered the alert), constructing a timeline, and testing hypotheses about the source through targeted environmental or staff screening where indicated. The ICC reviews the investigation's findings and approves corrective actions, which might range from reinforcing hand-hygiene compliance in the affected unit to a deeper environmental remediation if a source such as contaminated equipment is confirmed. NABH expects this entire sequence to be documented, since an undocumented outbreak response, even one that was handled well clinically, does not demonstrate a functioning surveillance programme to an assessor reviewing records months later.

This is also where the connection between infection control and reliable record-keeping becomes concrete. An outbreak investigation depends on being able to quickly pull every patient who was in a specific unit during a specific window, cross-referenced against lab results and procedure logs. A hospital reconstructing this from paper registers loses days it does not have; a hospital with structured digital records can generate the line listing in minutes.

What administrators should expect this to cost in staff time, not just in software

A functioning infection control programme is not free, regardless of what system supports it. It requires a trained ICO and ICN, dedicated time for surveillance activities, and management commitment to act on what the data shows even when the findings are uncomfortable. Software reduces the administrative burden of data collection and reporting, but it does not replace the clinical judgement of the ICO, the vigilance of the ICN doing rounds, or the willingness of hospital leadership to invest in isolation capacity, additional cleaning staff, or a training programme when the data shows a gap. Hospitals evaluating any infection control system, OneCity included, should be clear-eyed about this: the software makes a good programme easier to sustain and easier to prove to an assessor. It does not manufacture a programme that was not already committed to by the people running it.

Where software fits, and where it does not

OneCity does not run a hospital's infection control programme. That requires clinical leadership, trained ICNs, a functioning microbiology lab, and a management culture that treats infection prevention as a genuine priority rather than a compliance exercise. What OneCity's platform does is remove the manual data-collection burden that makes the programme harder to sustain than it needs to be.

Device-days for CLABSI, VAP, and CAUTI denominators come from the ICU charting module automatically, instead of being tallied by hand on a paper sheet. Hand-hygiene audit results can be logged digitally and aggregated into the compliance rate the ICC needs, rather than sitting in a notebook that has to be transcribed before every meeting. Antibiotic prescribing data from the pharmacy module can be cross-referenced against the formulary for the stewardship audit, instead of a pharmacist manually pulling prescriptions. BMW tracking integrates with the same biomedical waste module already managing the manifest and the CBWTF tie-up. And the ICC meeting agenda, minutes, and action-item tracking live in the same quality management system that tracks NABH's other committee and audit requirements, so nothing falls through a gap between departments.

The point is not automation for its own sake. It is making the data that a functioning ICC needs to review already exist in a usable form by the time the meeting happens, instead of requiring a manual data-collection sprint every quarter that burns the ICN's time and still produces numbers no one fully trusts.